AIM: To study the role of gene promoter hypermethylation of the putative tumour suppressor genes involved in the death-associated protein (DAP) kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in multiple myeloma (MM). METHOD: DNAs from 55 primary MM marrow samples and myeloma cell lines were analysed for aberrant promoter methylation of DAP kinase, p14 and Apaf-1 genes by methylation-specific polymerase chain reaction (MSP). RESULT: In the methylated positive control, the sensitivity of M-MSP for DAP kinase was 1 x 10(-3). Aberrant hypermethylation of DAP kinase was found in 29/55 (52.7%) primary MM samples, whereas hypermethylation of p14 or Apaf-1 was undetectable in any of the samples tested. 5-Azacytidine treatment of two myeloma cell lines, WL2 and HS-Sultan, led to de-methylation and re-expression of DAP kinase, thereby confirming gene silencing associated with promoter hypermethylation. Hypermethylation of DAP kinase did not correlate with age, sex, paraprotein subtype or Durie-Salmon stage, but negatively affected the overall survival. CONCLUSION: Of the putative tumour suppressor genes in the DAP kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway, only DAP kinase is frequently methylated in MM, which is associated with gene silencing and might be of prognostic significance. p14 and Apaf-1 were not methylated in MM.
AIM: To study the role of gene promoter hypermethylation of the putative tumour suppressor genes involved in the death-associated protein (DAP) kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in multiple myeloma (MM). METHOD: DNAs from 55 primary MM marrow samples and myeloma cell lines were analysed for aberrant promoter methylation of DAP kinase, p14 and Apaf-1 genes by methylation-specific polymerase chain reaction (MSP). RESULT: In the methylated positive control, the sensitivity of M-MSP for DAP kinase was 1 x 10(-3). Aberrant hypermethylation of DAP kinase was found in 29/55 (52.7%) primary MM samples, whereas hypermethylation of p14 or Apaf-1 was undetectable in any of the samples tested. 5-Azacytidine treatment of two myeloma cell lines, WL2 and HS-Sultan, led to de-methylation and re-expression of DAP kinase, thereby confirming gene silencing associated with promoter hypermethylation. Hypermethylation of DAP kinase did not correlate with age, sex, paraprotein subtype or Durie-Salmon stage, but negatively affected the overall survival. CONCLUSION: Of the putative tumour suppressor genes in the DAP kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway, only DAP kinase is frequently methylated in MM, which is associated with gene silencing and might be of prognostic significance. p14 and Apaf-1 were not methylated in MM.
Authors: T Taniguchi; N Chikatsu; S Takahashi; A Fujita; K Uchimaru; S Asano; T Fujita; T Motokura Journal: Leukemia Date: 1999-11 Impact factor: 11.528
Authors: H Avet-Loiseau; J Y Li; C Godon; N Morineau; A Daviet; J L Harousseau; T Facon; R Bataille Journal: Br J Haematol Date: 1999-09 Impact factor: 6.998
Authors: M Ben Dhiab; S Ziadi; F Ksiaa; T Louhichi; R Ben Gacem; A Ben Zineb; K Amara; M Hachana; Mounir Trimeche Journal: Tumour Biol Date: 2014-11-15
Authors: Amir A Toor; Kyle K Payne; Harold M Chung; Roy T Sabo; Allison F Hazlett; Maciej Kmieciak; Kimberly Sanford; David C Williams; William B Clark; Catherine H Roberts; John M McCarty; Masoud H Manjili Journal: Br J Haematol Date: 2012-07-23 Impact factor: 6.998
Authors: Kwan Yeung Wong; Chi Chiu So; Florence Loong; Lap Ping Chung; William Wai Lung Lam; Raymond Liang; George Kam Hop Li; Dong-Yan Jin; Chor Sang Chim Journal: PLoS One Date: 2011-04-22 Impact factor: 3.240
Authors: Chor Sang Chim; Kwan Yeung Wong; Chung Ying Leung; Lap Ping Chung; Pak Kwan Hui; Sau Yan Chan; Li Yu Journal: J Cell Mol Med Date: 2011-12 Impact factor: 5.310
Authors: Catharina Muylaert; Lien Ann Van Hemelrijck; Anke Maes; Kim De Veirman; Eline Menu; Karin Vanderkerken; Elke De Bruyne Journal: Front Oncol Date: 2022-08-18 Impact factor: 5.738
Authors: Lu Qian Wang; Yok Lam Kwong; Kit Fai Wong; Chi Shan Bonnie Kho; Dong Yan Jin; Eric Tse; Anders Rosèn; Chor Sang Chim Journal: J Transl Med Date: 2014-02-22 Impact factor: 5.531